SHAD JOHNSON: Open Payments
NPI 1114028354 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 46 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $354 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $379 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
| Phathom Pharmaceuticals, Inc. | 7 | $102 |
| Janssen Biotech, Inc. | 2 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| Gilead Sciences, Inc. | 4 | $78 |
| TerSera Therapeutics LLC | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $23 |
| GENZYME CORPORATION | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: SKYRIZI, RINVOQ, DUPIXENT, VOQUEZNA, TREMFYA, ENTYVIO, Xermelo, REZDIFFRA.
Industry payments across ID — which companies pay providers there.
